Trump's Selfishness on Display Yet Again with Threat to India

On April 6, US president Donald Trump said that there might be 'retaliation' if India does not release the US order for anti-malarial drug Hydroxychloroquin.

On April 6, US president Donald Trump said that there might be 'retaliation' if India does not release the US order for anti-malarial drug Hydroxychloroquin. This drug is said to be useful in the treatment of the COVID-19 virus that has wreaked a havoc in the entire world right now. In this video, NewsClick editor-in-chief Prabir Purkayastha talks about the implications of this threat, the need for global alliances to fight the disease and also the effectiveness of this drug which is now in high demand.